Vaerlose, Denmark

Soeren Berg Padkaer


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Location History:

  • Vaerloese, DK (2014)
  • Vaerlose, DK (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
2 patents (USPTO):

Title: Soeren Berg Padkaer: Innovator in Antibody Therapy

Introduction

Soeren Berg Padkaer is a notable inventor based in Vaerlose, Denmark. He has made significant contributions to the field of antibody therapy, particularly with his work on anti-NKG2A antibodies. With a total of 2 patents to his name, Padkaer is recognized for his innovative approaches to human therapy.

Latest Patents

Padkaer's latest patents focus on anti-NKG2A antibodies and their applications in human therapy. These patents describe anti-NKG2A antibodies that include humanized versions of the murine anti-NKG2A antibody Z270. The patents also detail related methods and materials for producing and utilizing such antibodies. Additionally, exemplary complementarity-determining regions (CDRs) sequences and sites for optional amino acid back-substitutions in the framework region (FR) and/or CDRs of these antibodies are included.

Career Highlights

Soeren Berg Padkaer is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk has allowed him to focus on developing innovative therapies that can significantly impact patient care.

Collaborations

Padkaer collaborates with Petrus Johannes Louis Spee, contributing to advancements in the field of antibody research and therapy.

Conclusion

Soeren Berg Padkaer is a prominent inventor whose work on anti-NKG2A antibodies is paving the way for new therapeutic options in human medicine. His contributions to the field are invaluable and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…